De Burlo Group Inc Inogen Inc Transaction History

De Burlo Group Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 07, 2019	SELL	$112.83 - $239.74 $3.14 Million - $6.66 Million	-27,800 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$189.1 - $282.92 $1.72 Million - $2.57 Million	-9,100 Reduced 24.66%	27,800 $6.79 Million
Q2 2018 Aug 10, 2018	BUY	$123.8 - $192.48 $1.63 Million - $2.54 Million	13,200 Added 55.7%	36,900 $6.88 Million
Q1 2018 May 03, 2018	SELL	$114.22 - $133.22 $1.52 Million - $1.77 Million	-13,300 Reduced 35.95%	23,700 $2.91 Million
Q4 2017 Feb 08, 2018	BUY	$93.4 - $128.74 $1.66 Million - $2.29 Million	17,800 Added 92.71%	37,000 $4.41 Million

Q3 2017 Nov 02, 2017	BUY	$91.08 - $104.49 $1.75 Million - $2.01 Million	19,200	19,200 $1.83 Million

138

21.9M

252K

183K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $189M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of De Burlo Group Inc, based on Form 13F filings with the SEC.

Stay updated on De Burlo Group Inc with notifications on news.